Co‐crosslinking FcϵRII/CD23 and B cell surface immunoglobulin modulates B cell activation
- 1 August 1992
- journal article
- Published by Wiley in European Journal of Immunology
- Vol. 22 (8), 2107-2112
- https://doi.org/10.1002/eji.1830220822
Abstract
Previous studies have shown that a highly multivalent from of anti‐IgD or anti‐IgM, prepared by conjugating the respective antibodies to dextran, causes extensive B cell proliferation with ng/ml concentrations of the anti‐immunoglobulin (Ig). A modification of this system has been exploited to investigate the effect of co‐crosslinking the FcϵRII and surface Ig by binding DNP to the dextran backbone (DNP‐dextran) and employing a DNP‐specific monoclonal IgE of either rat or mouse origin. Addition of anti‐IgD‐(Hδa/1)[DNP‐dextran] or anti‐IgM‐[DNP‐dextran] to purified, resting murine B cells resulted in B cell proliferation over a broad dose (0.03‐30 μg/ml). Addition of DNP‐specific rat or mouse IgE dramatically modulated the proliferative response. Proliferation in response to doses greater than 0.3 μg/ml Hδa/1‐[DNP‐dextran] was consistently reduced in a dose‐dependent manner in the presence of increasing amounts of IgE while proliferation to lower concentrations of Hδa/1‐[DNP‐dextran] was slightly enhanced or not influenced at all by the IgE anti‐DNP. Interleukin‐4 (IL‐4) significantly increased the IgE effect, in line with its known enhancing effects on FcϵRII levels. Experiments measuring Ig production rather than proliferation demonstrated that in the presence of IgE anti‐DNP, B cells produced lower amounts of immunoglobulin (IgG1 or IgM) in response to an anti‐Ig signal. Control experiments demonstrated that the IgE effect on proliferation was blocked by monoclonal anti‐FcϵRII, but not anti‐FcγRII, thus demonstrating the necessity for IgE/FcϵRII interaction. In addition, the necessity for co‐crosslinking was shown by the inability of IgE anti‐DNP to affect the proliferative response to Hδa/1‐dextran even in the presence of various doses of DNP‐dextran. These results demonstrate that co‐crosslinking of sIg and the FcϵRII results in an altered B cell response to anti‐Ig mediated activation. IL‐4 does not ablate this inhibition, in contrast to the effect of co‐crosslinking FcγRII and surface Ig, suggesting a model whereby IgE can modulate its own production.Keywords
This publication has 40 references indexed in Scilit:
- Genesis of host IgE competence: perinatal IgE tolerance induced by IgE processed and presented by IgE Fc receptor (CD23)‐bearing B cellsEuropean Journal of Immunology, 1992
- Characterization of new rat anti-mouse IgE monoclonals and their use along with chimeric IgE to further define the site that interacts with FcϵRII and FcϵRIMolecular Immunology, 1991
- Selectins: A family of adhesion receptorsCell, 1991
- Interleukin-4: a prototypic immunoregulatory lymphokineBlood, 1991
- Expression, Structure, and Function of the CD23 AntigenAdvances in Immunology, 1991
- IgE‐dependent antigen focusing by human B lymphocytes is mediated by the low‐affinity receptor for IgEEuropean Journal of Immunology, 1990
- Co‐cross‐linking of surface immunoglobulin Fcγ receptors on B lymphocytes uncouples the antigen receptors from their associated G proteinEuropean Journal of Immunology, 1989
- Modulation of IL‐4‐induced human IgE production in vitro by IFN‐γ and IL‐5: The role of soluble CD23 (s‐CD23)Journal of Cellular Biochemistry, 1989
- A chemical method for introducing haptens onto DNA probesAnalytical Biochemistry, 1988
- Molecular structure of human lymphocyte receptor for immunoglobulin ECell, 1986